IASO-782 in Autoimmune Hematological Diseases

Abroad (travel likely)RecruitingPHASE1

Conditions

Autoimmune Thrombocytopenia · Warm Autoimmune Haemolytic Anaemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Institute of Hematology, Chinese Academy of Medical Sciences, Tianjin, Tianjin Municipality, China
Contact: Study coordinator (Wen Ye) · wen.ye@iasobio.com · +86 18802071060

Study leads

Heng Mei
Principal Investigator
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia

Systemic Lupus Erythematosus · Immune Thrombocytopenia

Abroad (travel likely)RecruitingPHASE2, PHASE3

Beijing, China

Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia

Immune Thrombocytopenia

Abroad (travel likely)RecruitingPHASE1

Wuhan, China

Safety and Efficacy of PRG-1801 in Recurrent/Refractory Primary Immune Thrombocytopenia (ITP)

Immune Thrombocytopenia

Abroad (travel likely)RecruitingEARLY_PHASE1

Wuhan, China · Wuhan, China

Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia

Autoimmune Thrombocytopenia

Abroad (travel likely)RecruitingPHASE1

Beijing, China